Announcement

A innovative molecular “cut and sew” process by University of Dundee scientists has allowed the design of a research tool that will accelerate drug design for diseases for which no other options exist, including cancer.

Announcement

Dundee researchers have revealed in the greatest detail yet the workings of molecules called ‘protein degraders’ which can be deployed to combat what have previously been regarded as ‘undruggable’ diseases, including cancers and neurodegenerative diseases

Announcement

Experts from the University’s Centre for Targeted Protein Degradation (CeTPD), working with Boehringer Ingelheim scientists, have developed a breakthrough small-molecule drug, a “protein degrader”.

Announcement

Four early career researchers have been awarded fellowships that will allow them to join laboratories in the School of Life Sciences.

Announcement

One of Scotland’s most significant scientific success stories in recent times has been celebrated at a special event hosted by the University of Dundee.